PANAKARE PLUS- pancreatic enzyme tablet 
Neogen Corporation-Mercer

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

PanaKare Plus Tablets

Pancreatic Enzyme Concentrate

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FOR ANIMAL USE ONLY

Each tablet contains a minimum of:

Lipase..............................9,000 USP units

Protease.........................57,000 USP units

Amylase..........................64,000 USP units

Description:

PanaKare Plus is a pancreatic enzyme concentrate of porcine origin.

Precautions:

Discontinue use in animals with symptoms of sensitivity or allergy.

Made in the USA of U.S. and imported materials

KEEP OUT OF REACH OF CHILDREN

Indications:

As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

Directions for use:

Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

Average dose/meal:

Dogs: 2-3 tablets

Cats: 1/2-1 tablet

Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).

Manufactured by: Neogen Corporation

Lexington, KY 40511 859-254-1221

neogen.com

PRINCIPAL DISPLAY PANEL - 500 Tablet Bottle

NDC: 59051-9067-7

PanaKare Plus Tablets

Pancreatic Enzyme Concentrate

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Net Contents: 500 Tablets

PanaKare Plus Tablets 500ct

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle

NDC: 59051-9067-5

PanaKare Plus Tablets

Pancreatic Enzyme Concentrate

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Net Contents: 100 Tablets

PanaKare Plus Tablets 100ct

PANAKARE PLUS 
pancreatic enzyme tablet
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:59051-9067
Route of AdministrationOral
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PANCRELIPASE LIPASE (UNII: 8MYC33932O) (PANCRELIPASE LIPASE - UNII:8MYC33932O) PANCRELIPASE LIPASE9000 [iU]
PANCRELIPASE AMYLASE (UNII: YOJ58O116E) (PANCRELIPASE AMYLASE - UNII:YOJ58O116E) PANCRELIPASE AMYLASE64000 [iU]
PANCRELIPASE PROTEASE (UNII: 3560D81V50) (PANCRELIPASE PROTEASE - UNII:3560D81V50) PANCRELIPASE PROTEASE57000 [iU]
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize11mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:59051-9067-7500 in 1 BOTTLE, PLASTIC
2NDC:59051-9067-5100 in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/15/2013
Labeler - Neogen Corporation-Mercer (042125879)
Establishment
NameAddressID/FEIBusiness Operations
Neogen Corporation-Mercer042125879analysis, label, manufacture
Establishment
NameAddressID/FEIBusiness Operations
ALI Pharmaceutical Manufacturing, LLC080861914api manufacture
Establishment
NameAddressID/FEIBusiness Operations
Scientific Protein Laboratories LLC065240319api manufacture

Revised: 1/2024
Document Id: e9f5fc29-a7ed-48f5-8ff3-f166ea73b81a
Set id: c9b7ae4f-3463-4054-9ad8-b75b0bd3b20f
Version: 10
Effective Time: 20240123
 
Neogen Corporation-Mercer